What are the major opportunities in the Pneumococcal Vaccine market? What are the strategies for the Pneumococcal Vaccine market?

For detailed insights on the major opportunities and strategies in the Pneumococcal Vaccine market, Read More

How does the Pneumococcal Vaccine market relate to the overall economy and other similar markets?

For detailed insights on Pneumococcal Vaccine's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Pneumococcal Vaccine market growth? SWOT analysis of the Pneumococcal Vaccine market.

For detailed insights on the key dynamics influencing the Pneumococcal Vaccine market growth and SWOT analysis of the Pneumococcal Vaccine industry, Read More

Pneumococcal Vaccine Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Pneumococcal Vaccine Market Report 2026

Name: Pneumococcal Vaccine Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product Type (Prevnar 13, Synflorix, Pneumovax23, Other Products), By Route of Administration (Intravenous, Intramuscular, Subcutaneous), By Distribution Channel (Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels), By End User (Pediatrics, Adults) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pneumococcal Vaccine Market Overview

• Pneumococcal Vaccine market size has reached to $9.4 billion in 2025

• Expected to grow to $12.76 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%

• Growth Driver: Rising Prevalence Of Pneumococcal Contamination Drives Growth In Pneumococcal Vaccine Market

• Market Trend: Breakthrough In Vaccine For Enhanced Adult Protection

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pneumococcal Vaccine Market?

The pneumococcal vaccine refers to a vaccination that offers defense against potentially fatal and severe pneumococcal infections caused by streptococcus pneumoniae bacteria, such as pneumonia, meningitis, and sepsis. It is highly efficient in protecting infants from one of the most common causes of meningitis and other illnesses, such as acute ear infections.

The main pneumococcal vaccines are Prevnar 13, synflorix, pneumovax23, and others. Prevnar 13 refers to a pneumococcal conjugate vaccine containing 13 distinct strains of Streptococcus pneumoniae and it is used in children and tested on immunocompromised patients to prevent pneumococcal disease. The various routes of administration include intravenous, intramuscular, and subcutaneous and are distributed via pharmacies, community clinics, public health agencies, and other distribution channels to end users such as pediatrics and adults.

Pneumococcal Vaccine Market Global Report 2026 Market Report bar graph

What Is The Pneumococcal Vaccine Market Size and Share 2026?

The pneumococcal vaccine market size has grown strongly in recent years. It will grow from $9.4 billion in 2025 to $9.94 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to high childhood pneumonia burden, inclusion in national immunization programs, strong support from global health organizations, rising awareness of invasive pneumococcal disease, proven efficacy of pcv vaccines.

What Is The Pneumococcal Vaccine Market Growth Forecast?

The pneumococcal vaccine market size is expected to see strong growth in the next few years. It will grow to $12.76 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to launch of next-generation pcv vaccines, expanding adult vaccination recommendations, growth in healthcare access in emerging economies, increasing antimicrobial resistance concerns, government funding for preventive immunization. Major trends in the forecast period include expansion of conjugate vaccines for broader serotype coverage, increased focus on pediatric and geriatric immunization programs, rising adoption of combination and booster vaccination strategies, strengthening public–private partnerships for immunization coverage, growth in preventive healthcare and national immunization schedules.

Book your 30 minutes free consultation with our research experts

Global Pneumococcal Vaccine Market Segmentation

1) By Product Type: Prevnar 13, Synflorix, Pneumovax23, Other Products

2) By Route of Administration: Intravenous, Intramuscular, Subcutaneous

3) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels

4) By End User: Pediatrics, Adults

Subsegments:

1) By Prevnar 13: Pediatric Formulation, Adult Formulation

2) By Synflorix: Pediatric Formulation, Adult Formulation

3) By Pneumovax23: Single-Dose Vials, Pre-Filled Syringes

4) By Other Products: PCV15 (Vaxneuvance), PCV20 (Prevnar 20), Other Regional Pneumococcal Vaccines

What Is The Driver Of The Pneumococcal Vaccine Market?

The increasing prevalence of pneumococcal contamination is expected to propel the growth of the pneumococcal vaccine market going forward. Pneumococcal contamination refers to any infection caused by bacteria called Streptococcus pneumoniae or pneumococcus, such as pneumonia, bloodstream infections, ear infections, and sinus infections. The pneumococcal vaccine stimulates the body to produce antibodies against pneumococcal bacteria to reduce or destroy disease-carrying bacteria and toxins to protect children, the elderly, and those with weakened immune systems from many types of pneumococcal infections. For instance, in July 2025, according to the Immunisation Coalition, a Australia-based, independent not-for-profit charity, cases of invasive pneumococcal disease (IPD) have steadily increased each year, growing from 1,869 in 2022 to 2,265 in 2023, and reaching 2,379 in 2024. Therefore, the increasing prevalence of pneumococcal contamination is driving the growth of the pneumococcal vaccine industry.

Key Players In The Global Pneumococcal Vaccine Market

Major companies operating in the pneumococcal vaccine market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, CSL Limited, Anhui Zhifei Longcom Biopharmaceutical Co. Ltd, Serum Institute of India Private Limited, Walvax Biotechnology Co. Ltd, Biological E Limited, Hualan Biological Engineering Inc., Beijing Minhai Biotechnology Limited Company, NPO Petrovax Pharm LLC, Vaxcyte Inc., Panacea Biotec Ltd, PnuVax Incorporated, SK Bioscience Co Ltd, Bharat Biotech International Ltd, Medicago Inc., Emergent BioSolutions Inc., Valneva SE

Global Pneumococcal Vaccine Market Trends and Insights

Major companies operating in the pneumococcal vaccine market are innovating new products to increase their profitability in the market. For instance, in July 2023, Merck & Co Inc., a US-based pharmaceuticals company launched the V116 vaccine. V116 is intended to target the eight distinct serotypes of Streptococcus pneumoniae that are primarily responsible for adult pneumococcal disease. Compared to other pneumococcal vaccines, V116 has shown better immunogenicity for a variety of serotypes in adult populations, and it has also produced positive immune responses in both vaccine-naïve and previously vaccinated individuals. The U.S. Food and Drug Administration (FDA) has designated V116 as a breakthrough therapy, and it is currently in Phase 3 development.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Pneumococcal Vaccine Market?

In December 2024, Sanofi SA, a France-based pharmaceutical company, expanded its collaboration with SK Bioscience Co. Ltd. to advance the development of its licensed pneumococcal conjugate vaccine. Through this collaboration expansion, Sanofi aims to accelerate late-stage development and strengthen its pneumococcal vaccine portfolio by leveraging SK Bioscience’s advanced vaccine manufacturing and development capabilities. SK Bioscience Co. Ltd. is a South Korea-based biotechnology company specializing in pneumococcal vaccine R&D and biomanufacturing.

Regional Insights

North America was the largest region in the pneumococcal vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pneumococcal Vaccine Market?

The pneumococcal vaccine market consists of sales of vaxneuvance, prevnar 20, pneumococcal conjugate vaccines (PCV)10, and pneumococcal conjugate vaccines (PCV)7. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pneumococcal Vaccine Market Report 2026?

The pneumococcal vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pneumococcal vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Pneumococcal Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$9.94 billion
Revenue Forecast In 2035	$12.76 billion
Growth Rate	CAGR of 5.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product Type, Route of Administration, Distribution Channel, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, CSL Limited, Anhui Zhifei Longcom Biopharmaceutical Co. Ltd, Serum Institute of India Private Limited, Walvax Biotechnology Co. Ltd, Biological E Limited, Hualan Biological Engineering Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Pneumococcal Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Pneumococcal Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Pneumococcal Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Pneumococcal Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Expansion Of Conjugate Vaccines For Broader Serotype Coverage

4.2.2 Increased Focus On Pediatric And Geriatric Immunization Programs

4.2.3 Rising Adoption Of Combination And Booster Vaccination Strategies

4.2.4 Strengthening Public–Private Partnerships For Immunization Coverage

4.2.5 Growth In Preventive Healthcare And National Immunization Schedules

5. Pneumococcal Vaccine Market Analysis Of End Use Industries

5.1 Pediatric Hospitals

5.2 Adult Hospitals

5.3 Community Health Centers

5.4 Government Immunization Programs

5.5 Private Clinics

6. Pneumococcal Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pneumococcal Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Pneumococcal Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Pneumococcal Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Pneumococcal Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Pneumococcal Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pneumococcal Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pneumococcal Vaccine Market Segmentation

9.1. Global Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prevnar 13, Synflorix, Pneumovax23, Other Products

9.2. Global Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous, Intramuscular, Subcutaneous

9.3. Global Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels

9.4. Global Pneumococcal Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatrics, Adults

9.5. Global Pneumococcal Vaccine Market, Sub-Segmentation Of Prevnar 13, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric Formulation, Adult Formulation

9.6. Global Pneumococcal Vaccine Market, Sub-Segmentation Of Synflorix, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric Formulation, Adult Formulation

9.7. Global Pneumococcal Vaccine Market, Sub-Segmentation Of Pneumovax23, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single-Dose Vials, Pre-Filled Syringes

9.8. Global Pneumococcal Vaccine Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

PCV15 (Vaxneuvance), PCV20 (Prevnar 20), Other Regional Pneumococcal Vaccines

10. Pneumococcal Vaccine Market Regional And Country Analysis

10.1. Global Pneumococcal Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Pneumococcal Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pneumococcal Vaccine Market

11.1. Asia-Pacific Pneumococcal Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pneumococcal Vaccine Market

12.1. China Pneumococcal Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pneumococcal Vaccine Market

13.1. India Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pneumococcal Vaccine Market

14.1. Japan Pneumococcal Vaccine Market Overview

14.2. Japan Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pneumococcal Vaccine Market

15.1. Australia Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pneumococcal Vaccine Market

16.1. Indonesia Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pneumococcal Vaccine Market

17.1. South Korea Pneumococcal Vaccine Market Overview

17.2. South Korea Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pneumococcal Vaccine Market

18.1. Taiwan Pneumococcal Vaccine Market Overview

18.2. Taiwan Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pneumococcal Vaccine Market

19.1. South East Asia Pneumococcal Vaccine Market Overview

19.2. South East Asia Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pneumococcal Vaccine Market

20.1. Western Europe Pneumococcal Vaccine Market Overview

20.2. Western Europe Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pneumococcal Vaccine Market

21.1. UK Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pneumococcal Vaccine Market

22.1. Germany Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pneumococcal Vaccine Market

23.1. France Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pneumococcal Vaccine Market

24.1. Italy Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pneumococcal Vaccine Market

25.1. Spain Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pneumococcal Vaccine Market

26.1. Eastern Europe Pneumococcal Vaccine Market Overview

26.2. Eastern Europe Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pneumococcal Vaccine Market

27.1. Russia Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pneumococcal Vaccine Market

28.1. North America Pneumococcal Vaccine Market Overview

28.2. North America Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pneumococcal Vaccine Market

29.1. USA Pneumococcal Vaccine Market Overview

29.2. USA Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pneumococcal Vaccine Market

30.1. Canada Pneumococcal Vaccine Market Overview

30.2. Canada Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pneumococcal Vaccine Market

31.1. South America Pneumococcal Vaccine Market Overview

31.2. South America Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pneumococcal Vaccine Market

32.1. Brazil Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pneumococcal Vaccine Market

33.1. Middle East Pneumococcal Vaccine Market Overview

33.2. Middle East Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pneumococcal Vaccine Market

34.1. Africa Pneumococcal Vaccine Market Overview

34.2. Africa Pneumococcal Vaccine Market, Segmentation By Product Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pneumococcal Vaccine Market Regulatory and Investment Landscape

36. Pneumococcal Vaccine Market Competitive Landscape And Company Profiles

36.1. Pneumococcal Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Pneumococcal Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Pneumococcal Vaccine Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

37. Pneumococcal Vaccine Market Other Major And Innovative Companies

Anhui Zhifei Longcom Biopharmaceutical Co. Ltd, Serum Institute of India Private Limited, Walvax Biotechnology Co. Ltd, Biological E Limited, Hualan Biological Engineering Inc., Beijing Minhai Biotechnology Limited Company, NPO Petrovax Pharm LLC, Vaxcyte Inc., Panacea Biotec Ltd, PnuVax Incorporated, SK Bioscience Co Ltd, Bharat Biotech International Ltd, Medicago Inc., Emergent BioSolutions Inc., Valneva SE

38. Global Pneumococcal Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pneumococcal Vaccine Market

40. Pneumococcal Vaccine Market High Potential Countries, Segments and Strategies

40.1 Pneumococcal Vaccine Market In 2030 - Countries Offering Most New Opportunities

40.2 Pneumococcal Vaccine Market In 2030 - Segments Offering Most New Opportunities

40.3 Pneumococcal Vaccine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Pneumococcal Vaccine Market, Overview Of Key Products - Product Examples

Table 2: Global Pneumococcal Vaccine Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Pneumococcal Vaccine Market, Supply Chain Analysis

Table 4: Global Pneumococcal Vaccine Market, Major Raw Material Providers

Table 5: Global Pneumococcal Vaccine Market, Major Resource Providers

Table 6: Global Pneumococcal Vaccine Market, Major Manufacturers (Suppliers)

Table 7: Global Pneumococcal Vaccine Market, Major Distributors And Channel Partners

Table 8: Global Pneumococcal Vaccine Market, Key Technologies & Future Trends

Table 9: Global Pneumococcal Vaccine Market, Major Trends

Table 10: Global Pneumococcal Vaccine Market, Major End Users

Table 11: Global Pneumococcal Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Pneumococcal Vaccine Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Pneumococcal Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Pneumococcal Vaccine Market - TAM, US$ Billion, 2025

Table 15: Global Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Pneumococcal Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Pneumococcal Vaccine Market, Sub-Segmentation Of Prevnar 13, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Pneumococcal Vaccine Market, Sub-Segmentation Of Synflorix, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Pneumococcal Vaccine Market, Sub-Segmentation Of Pneumovax23, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Pneumococcal Vaccine Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Pneumococcal Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Pneumococcal Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Pneumococcal Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Pneumococcal Vaccine Market - Company Scoring Matrix

Table 99: Pfizer Inc. Financial Performance

Table 100: Merck & Co. Inc. Financial Performance

Table 101: Sanofi S.A. Financial Performance

Table 102: GlaxoSmithKline plc Financial Performance

Table 103: CSL Limited Financial Performance

Table 104: Global Pneumococcal Vaccine Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Pneumococcal Vaccine Market, Competitive Dashboard

Table 106: Global Pneumococcal Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Pneumococcal Vaccine Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 108: Global, Pneumococcal Vaccine Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

Table 109: Global, Pneumococcal Vaccine Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Pneumococcal Vaccine Market, Overview Of Key Products - Product Examples

Figure 2: Global Pneumococcal Vaccine Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Pneumococcal Vaccine Market, Supply Chain Analysis

Figure 4: Global Pneumococcal Vaccine Market, Major Raw Material Providers

Figure 5: Global Pneumococcal Vaccine Market, Major Resource Providers

Figure 6: Global Pneumococcal Vaccine Market, Major Manufacturers (Suppliers)

Figure 7: Global Pneumococcal Vaccine Market, Major Distributors And Channel Partners

Figure 8: Global Pneumococcal Vaccine Market, Key Technologies & Future Trends

Figure 9: Global Pneumococcal Vaccine Market, Major Trends

Figure 10: Global Pneumococcal Vaccine Market, Major End Users

Figure 11: Global Pneumococcal Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Pneumococcal Vaccine Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Pneumococcal Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Pneumococcal Vaccine Market - TAM, US$ Billion, 2025

Figure 15: Global Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Pneumococcal Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Pneumococcal Vaccine Market, Sub-Segmentation Of Prevnar 13, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Pneumococcal Vaccine Market, Sub-Segmentation Of Synflorix, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Pneumococcal Vaccine Market, Sub-Segmentation Of Pneumovax23, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Pneumococcal Vaccine Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Pneumococcal Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Pneumococcal Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Pneumococcal Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Pneumococcal Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Pneumococcal Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Pneumococcal Vaccine Market - Company Scoring Matrix

Figure 99: Pfizer Inc. Financial Performance

Figure 100: Merck & Co. Inc. Financial Performance

Figure 101: Sanofi S.A. Financial Performance

Figure 102: GlaxoSmithKline plc Financial Performance

Figure 103: CSL Limited Financial Performance

Figure 104: Global Pneumococcal Vaccine Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Pneumococcal Vaccine Market, Competitive Dashboard

Figure 106: Global Pneumococcal Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Pneumococcal Vaccine Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 108: Global, Pneumococcal Vaccine Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

Figure 109: Global, Pneumococcal Vaccine Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Chickenpox Vaccine Market Report 2026 - Global Outlook – By Vaccine (Monovalent Varicella Vaccine, Combination Varicella Vaccine), By Application (Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immuni...

Preventive Vaccines Market Report 2026 - Global Outlook – By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By ...

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global ...

Pneumococcal Vaccine Market Report 2026 - Global Outlook – By Product Type (Prevnar 13, Synflorix, Pneumovax23, Other Products), By Route of Administration (Intravenous, Intramuscular, Subcutaneous), By Distribution Chan...

Meningococcal Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine), By Serotype (Men Acwy, Men B/Bc, Men C), By Age Group (Infants, Childre...

Meningococcal Disease Vaccine Market Report 2026 - Global Outlook – By Vaccine Type (Conjugate Vaccines, Polysaccharide Vaccines, Recombinant Vaccines, Live Attenuated Vaccines), By Age Group (Infants, Children, Adults, ...

Respiratory Disease Vaccine Market Report 2026 - Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other In...

Frequently Asked Questions

How big is the Pneumococcal Vaccine Market?

The Pneumococcal Vaccine market was valued at $9.4 billion in 2025, increased to $9.94 billion in 2026, and is projected to reach $12.76 billion by 2030. request a sample here

What is the Pneumococcal Vaccine market growth?

The global Pneumococcal Vaccine market is expected to grow at a CAGR of 6.5% from 2026 to 2035 to reach $12.76 billion by 2035. request a sample here

Who are the key players in Pneumococcal Vaccine market?

Some Key Players in the Pneumococcal Vaccine market Include, Pfizer Inc., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, CSL Limited, Anhui Zhifei Longcom Biopharmaceutical Co. Ltd, Serum Institute of India Private Limited, Walvax Biotechnology Co. Ltd, Biological E Limited, Hualan Biological Engineering Inc., Beijing Minhai Biotechnology Limited Company, NPO Petrovax Pharm LLC, Vaxcyte Inc., Panacea Biotec Ltd, PnuVax Incorporated, SK Bioscience Co Ltd, Bharat Biotech International Ltd, Medicago Inc., Emergent BioSolutions Inc., Valneva SE . request a sample here

What is the anticipated growth trend for the Pneumococcal Vaccine market?

Major trend in this market includes: Breakthrough In Vaccine For Enhanced Adult Protection. For further insights on this market. request a sample here

Which region has the most growth potential in the Pneumococcal Vaccine market?

North America was the largest region in the pneumococcal vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumococcal vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Pneumococcal Vaccine Market Report 2026 market?

Major companies operating in the Pneumococcal Vaccine Market Report 2026 market are Major companies operating in the pneumococcal vaccine market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, CSL Limited, Anhui Zhifei Longcom Biop request a sample here.